Glucose-Reduced Graphene Oxide with Excellent Biocompatibility and Photothermal Efficiency as well as Drug Loading

葡萄糖还原氧化石墨烯具有优异的生物相容性、光热效率和载药能力

阅读:1

Abstract

In the present work, we report a facile and rapid green strategy to fabricate functionalized reduced nano-graphene oxide (nrGO) as a cooperative nanotemplate for both photothermal therapy and drug loading. Graphite oxide was firstly oxidated by nitronium ions (NO2 (+)) solution at the aid of microwave heating to obtain nano-GO (nGO) with about 50 nm of diameter, and the nGO was then reduced in pure glucose at 135 °C for 30 min to obtain nrGO with about 40 nm of diameter. The nrGO exhibits excellent biocompatibility including stable dispersibility in cell culture medium and rapid cellular uptake as well as non-cytotoxicity up to 100 μg/mL. Absorption of the nrGO at 808 nm wavelength increased more than 10-folds compared with nGO. Moreover, the nrGO has the ability to load about 317 % (w/w) of doxorubicin (DOX), and the loaded DOX could be effectively released by acid condition and/or glutathione (GSH) and/or heating. Finally, a greater cancer cell death efficacy was observed in nrGO/DOX-treated cells with GSH and heating stimulation respectively or their combination. Collectively, the nrGO developed here is an outstanding cooperative nano-platform for high-efficiency photothermal therapy and controllable drug delivery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。